Publications

Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy.

Meng X, Chao B, Chen F, Huang R, Taneja SS, Deng FM, 2021 Mar J Urol 3 205 748-754

Application of the PRECISION Trial Biopsy Strategy to a Contemporary Magnetic Resonance Imaging-Targeted Biopsy Cohort-How Many Clinically Significant Prostate Cancers are Missed?

Feuer Z, Meng X, Rosenkrantz AB, Kasivisvanathan V, Moore CM, Huang R, Deng FM, Lepor H, Wysock JS, Huang WC, Taneja SS, 2021 03 J Urol 3 205 740-747

Robotic Nephroureterectomy vs. Laparoscopic Nephroureterectomy: Increased Utilization, Rates of Lymphadenectomy, Decreased Morbidity Robotically.

Kenigsberg A, Smith W, Meng X, Ghandour R, Rapoport L, Bagrodia A, Lotan Y, Woldu S, Margulis V, 2020 Oct J Endourol

Prospective evaluation of blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.

Lotan Y, Chaplin I, Ahmadi H, Meng X, Roberts S, Ladi-Seyedian S, Bagrodia A, Margulis V, Woldu S, Daneshmand S, 2020 Jul BJU Int.

Does grossly complete transurethral resection improve response to neoadjuvant chemotherapy?

Ghandour RA, Kusin S, Wong D, Meng X, Singla N, Freifeld Y, Bagrodia A, Margulis V, Sagalowsky A, Lotan Y, Woldu SL, 2020 Jul Urol. Oncol.

Oncologic outcomes of radical nephroureterectomy (RNU).

Kenigsberg AP, Meng X, Ghandour R, Margulis V, 2020 Aug 4 9 1841-1852

Real-World Application of Pre-orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.

Badia RR, Abe D, Wong D, Singla N, Savelyeva A, Chertack N, Woldu SL, Lotan Y, Mauck R, Ouyang D, Meng X, Lewis CM, Majmudar K, Jia L, Kapur P, Xu L, Frazier AL, Margulis V, Strand DW, Coleman N, Murray MJ, Amatruda JF, Lafin JT, Bagrodia A, 2020 Aug J. Urol. 101097JU0000000000001337

Feasibility and Safety of Robotic Excision of Ipsilateral Retroperitoneal Recurrence after Nephrectomy for Renal Cell Carcinoma.

Ghandour R, Miranda AF, Singla N, Meng X, Enikeev D, Woldu S, Bagrodia A, Cadeddu J, Gahan J, Margulis V, 2020 Aug Urology

Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital.

Chertack N, Ghandour RA, Singla N, Freifeld Y, Hutchinson RC, Courtney K, Bowman IA, Arafat W, Meng X, Moore JA, Aydin AM, Sagalowsky AI, Margulis V, Lotan Y, Woldu SL, Bagrodia A, 2020 Aug Cancer

Tumor location does not limit percutaneous treatment of small renal masses with microwave ablation.

Meng X, Ghandour R, Margulis V, 2019 Sep Ann Transl Med Suppl 6 7 S231

Critical treatment choices for patients with platinum-refractory urothelial carcinoma.

Lotan Y, Meng X, 2019 Nov Lancet Oncol.

Advancements in the clinical management of upper tract urothelial carcinoma.

Taylor J, Meng X, Ghandour R, Margulis V, 2019 Nov Expert Rev Anticancer Ther

High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma.

Meng X, Chao B, Vijay V, Silver H, Margolin EJ, Balar A, Taneja SS, Shah O, Bjurlin MA, Anderson CB, Huang WC, 2019 Jul Urology 129 146-152

Different models for prediction of radical cystectomy postoperative complications and care pathways.

Taylor J, Meng X, Renson A, Smith AB, Wysock JS, Taneja SS, Huang WC, Bjurlin MA, 2019 Jan-Dec Ther Adv Urol 11 1756287219875587

Necl-4/Cadm4 recruits Par-3 to the Schwann cell adaxonal membrane.

Meng X, Maurel P, Lam I, Heffernan C, Stiffler MA, McBeath G, Salzer JL, 2019 05 Glia 5 67 884-895

Discordance Between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma.

Margolin EJ, Matulay JT, Li G, Meng X, Chao B, Vijay V, Silver H, Clinton TN, Krabbe LM, Woldu SL, Singla N, Bagrodia A, Margulis V, Huang WC, Bjurlin MA, Shah O, Anderson CB 2018 Feb J. Urol.

The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years.

Meng X, Rosenkrantz AB, Huang R, Deng FM, Wysock JS, Bjurlin MA, Huang WC, Lepor H, Taneja SS, 2018 11 J Urol 5 200 1022-1029

Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index.

Meng X, Press B, Renson A, Wysock JS, Taneja SS, Huang WC, Bjurlin MA, 2018 08 Clin Genitourin Cancer 4 16 e843-e850

Role of prostate magnetic resonance imaging in active surveillance.

Meng X, Rosenkrantz AB, Taneja SS, 2017 Jun Transl Androl Urol 3 6 444-452

Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.

Meng X, Rosenkrantz AB, Mendhiratta N, Fenstermaker M, Huang R, Wysock JS, Bjurlin MA, Marshall S, Deng FM, Zhou M, Melamed J, Huang WC, Lepor H, Taneja SS, 2016 Mar Eur Urol 3 69 512-7

Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy.

Rosenkrantz AB, Meng X, Ream JM, Babb JS, Deng FM, Rusinek H, Huang WC, Lepor H, Taneja SS, 2016 Feb J Magn Reson Imaging 2 43 325-32

Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy.

Fenstermaker M, Mendhiratta N, Bjurlin MA, Meng X, Rosenkrantz AB, Huang R, Deng FM, Zhou M, Huang WC, Lepor H, Taneja SS 2016 Aug Urology

Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.

Domènech-Estévez E, Baloui H, Meng X, Zhang Y, Deinhardt K, Dupree JL, Einheber S, Chrast R, Salzer JL, 2016 Apr J Neurosci 16 36 4506-21

Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.

Wysock JS, Mendhiratta N, Zattoni F, Meng X, Bjurlin M, Huang WC, Lepor H, Rosenkrantz AB, Taneja SS, 2016 10 BJU Int 4 118 515-20

Editorial Comment.

Meng X, Taneja SS, 2016 08 J Urol 2 196 365

Using multiparametric MRI to 'personalize' biopsy for men.

Mendhiratta N, Meng X, Taneja SS, 2015 Nov Curr Opin Urol 6 25 498-503

Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.

Mendhiratta N, Meng X, Rosenkrantz AB, Wysock JS, Fenstermaker M, Huang R, Deng FM, Melamed J, Zhou M, Huang WC, Lepor H, Taneja SS, 2015 Dec Urology 6 86 1192-8

Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification.

Mendhiratta N, Rosenkrantz AB, Meng X, Wysock JS, Fenstermaker M, Huang R, Deng FM, Melamed J, Zhou M, Huang WC, Lepor H, Taneja SS, 2015 Dec J Urol 6 194 1601-6

Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment.

Bjurlin MA, Meng X, Le Nobin J, Wysock JS, Lepor H, Rosenkrantz AB, Taneja SS, 2014 Sep J Urol 3 192 648-58

The 4.1B cytoskeletal protein regulates the domain organization and sheath thickness of myelinated axons.

Einheber S, Meng X, Rubin M, Lam I, Mohandas N, An X, Shrager P, Kissil J, Maurel P, Salzer JL 2013 Feb Glia 2 61 240-53

Assembly and maintenance of nodes of ranvier rely on distinct sources of proteins and targeting mechanisms.

Zhang Y, Bekku Y, Dzhashiashvili Y, Armenti S, Meng X, Sasaki Y, Milbrandt J, Salzer JL, 2012 Jan Neuron 1 73 92-107